The sneaky virus poses serious health threats if it goes on to become a chronic disease. Clinical trial results suggest a new drug may cure 1 in 5 of those cases.
A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver ...
Hepatitis B is not a particularly common condition in the United States. Data from 2021 estimates that between 880,000 and 1.89 million individuals are living with chronic hepatitis B in the U.S. This ...
Hepatitis B and herpes simplex virus are both sexually transmitted infections (STIs). However, they are not the same and develop due to different viruses. STIs spread from one person to another ...
The study comes months after the Advisory Committee on Immunization Practices (ACIP) voted in December 2025 to replace its ...
A major clinical trial found that one in five people with chronic hepatitis B could control the virus without further ...
New research implies that a first-of-its-kind drug for hepatitis B could allow some patients to stop treatment without ...
A single hepatitis B injection set off a lasting immune response, and two patients reached a functional cure that held for ...
If someone presents you with a hepatitis B declination form, you might have some questions about it and the hepatitis B vaccine more generally. Hepatitis B is an infection of the liver due to the ...
9d
How a new drug shows promise as a 'functional cure' for Long Island's chronic hepatitis B patients
In about 20% of the drug's recipients, the virus remained undetectable for at least six months after all treatments were ...
United States President Donald Trump this week claimed children should not be vaccinated against hepatitis B until they are 12 years old, rather than at birth. He also said the viral liver infection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results